LarmorBio Analysis: $2M Raised
What is LarmorBio?
LarmorBio develops microscale magnetic resonance technology for live cell phenotyping and clinical diagnostics. Their platform offers a rapid, low-cost test for oxidative stress, a key marker for metabolic dysregulation. The company engages in global clinical trials to provide insights into early disease mechanisms.
Location
414 Crescent Street, Waltham, Massachusetts 02453, United States
Employees
1-10
Founded
2021
Funding Status
Seed
Product Features & Capabilities
- Rapid oxidative stress testing
- Live cell phenotyping technology
- Clinical trial engagement for disease insights
Use Cases
Conduct rapid blood tests for oxidative stress in under 5 minutes; Provide researchers with insights into metabolic dysregulation; Support clinical trials for early disease detection; Enable diagnostics for chronic disease progression; Facilitate live cell analysis in research settings
See something that needs updating? Suggest edits to this profile.